- My PDC
- Contact Us
ANSYS came to UCSF on September 26 and put on a great seminar on the uses and capabilities of their simulation software for various medical and biomedical applications. It was eye-opening to see how their modeling software can accelerate the development of medical devices. Through ANSYS's academic partnership with UCSF, PDC members are using ANSYS software to optimize their device designs and streamline the prototyping process.
The PDC's Magnamosis project took top honors in the ASAIO 2nd Annual Medical Device Entrepreneur’s Forum, part of the ASAIO's 59th Annual Conference in Chicago in June. The three finalists, all award-winning entrepreneurs with innovative medical device technologies, presented their business plans before a panel with expertise in regulatory, reimbursement, intellectual property, and venture capital. The goal of the forum is to foster interaction and education among clinical, research, industry and government stakeholders toward understanding strategies that accelerate the commercialization of innovative medical technologies.
San Francisco State University graduate student Shad Kish won first place in the Engineering and Computer Sciences category at the California State University Research Competition on May 10-11 for her presentation, "Miniaturizing RFID for Biomedical Implants." Shad's work with her mentor, San Francisco State engineering professor Hao Jiang, PhD, was inspired by needs for the PDC's Magnamosis device.
“Innovation in medicine is driven by need, but also by the market,” said Dr. Michael R. Harrison, the director emeritus of the Fetal Treatment Center and the director of the Pediatric Device Consortium, both at UCSF. “Big markets have lots of folks developing devices, but small markets like the pediatrics market don’t.” Read the The New York Times' Well blog's coverage of the challenges involved in pediatric medical device development.
Shuvo Roy, PhD, a UCSF bioengineer and the technical director of the UCSF-led effort to create the first implantable artificial kidney, was recently on Capitol Hill to inform congressional staff about the device. The kidney project is now featured in the UC Office of the President's Onward California campaign, which aims to educate Californians about the impact the University has in their lives. Read more and watch the video here.
Four devices assisted by the PDC, including a bioartificial pancreas for patients with type 1 diabetes, a mobility device to increase patient ambulation, a biocompatible underwater sealant to prevent preterm birth from fetal intervention, and an intravenous chemotherapy filter, were among the finalists in the UCSF CTSI’s Catalyst Award Program, which aims to accelerate translation of promising early-stage research ideas to patient benefit. Read more about the program and winning projects here.
The digital health incubator Rock Health and UCSF's Clinical and Translational Science Institute (CTSI) co-sponsored a "Meeting of the Minds" on March 5th at the Mission Bay campus. The goal of the meetup, organized by UCSF orthopedic surgeon and PDC member Aenor Sawyer, MD, was to bring together healthcare providers who have specific pain points with technologists eager to develop solutions. Read the Forbes.com article here.
Innovation can be born of necessity, conscience, creativity, luck, or more likely, all of the above, all at once. Whatever the impetus, the active ingredient of invention is collaboration.
The five scientists highlighted here — bioengineers Tejal Desai and Shuvo Roy, MD/PhD candidate Mozziyar Etemadi, microbiologist Joe DeRisi, and physician/surgeon Michael Harrison — trace intersecting paths, tapping each other’s expertise nearly constantly. Read the UCSF Magazine cover story.
Michael R. Harrison, MD, director of the Pediatric Device Consortium and founder and director emeritus of the UCSF Fetal Treatment Center, was honored last week for his achievements and innovation in fetal surgery with the Ronald McDonald House Charities Medical Award of Excellence. Harrison joins an exclusive group of notable physicians, philanthropists, celebrities, business executives and professional athletes who have made outstanding contributions to improve the health and well-being of children. Read the UCSF News story here.
UCSF bioengineer Shuvo Roy, PhD, has been elected to the BayBio Pantheon, a group of 52 San Francisco Bay Area life sciences leaders who have made a significant contribution to the industry, for his work toward creating the world’s first implantable artificial kidney. Roy is the seventh UCSF faculty member to be elected to the BayBio Pantheon since its inception in 2004. Read the story here.